VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹28 Cr | ₹27 Cr | ₹41 Cr | ₹62 Cr | ₹-10.00 Cr |
What is the latest Consolidated Net Profit of VENUS REMEDIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹28 Cr |
Mar2023 | ₹27 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹62 Cr |
Mar2020 | ₹-10.00 Cr |
How is Consolidated Net Profit of VENUS REMEDIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹28 Cr | 7.25 | |
Mar2023 | ₹27 Cr | -34.77 | |
Mar2022 | ₹41 Cr | -34.07 | |
Mar2021 | ₹62 Cr | Positive | |
Mar2020 | ₹-10.00 Cr | - |
Compare Consolidated Net Profit of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹723.8 Cr | 8.1% | 24.9% | 43.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 8.1% |
24.9% |
43.5% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses